PT Kalbe Farma Tbk. (PTKFF)

USD 0.1

(0.0%)

Total Debt Summary of PT Kalbe Farma Tbk.

PT Kalbe Farma Tbk.'s latest annual total debt in 2023 was 40.4 Million USD , down -45.93% from previous year.
PT Kalbe Farma Tbk.'s latest quarterly total debt in 2024 Q2 was 62.09 Million USD , up 40.56% from previous quarter.
PT Kalbe Farma Tbk. reported annual total debt of 74.73 Million USD in 2022, up 70.51% from previous year.
PT Kalbe Farma Tbk. reported annual total debt of 43.83 Million USD in 2021, down -46.81% from previous year.
PT Kalbe Farma Tbk. reported quarterly total debt of 44.17 Million USD for 2024 Q1, up 9.33% from previous quarter.
PT Kalbe Farma Tbk. reported quarterly total debt of 62.09 Million USD for 2024 Q2, up 40.56% from previous quarter.

Annual Total Debt Chart of PT Kalbe Farma Tbk. (2023 - 2015)

Historical Annual Total Debt of PT Kalbe Farma Tbk. (2023 - 2015)

Year	Total Debt	Total Debt Growth
2023	40.4 Million USD	-45.93%
2022	74.73 Million USD	70.51%
2021	43.83 Million USD	-46.81%
2020	82.4 Million USD	40.05%
2019	58.83 Million USD	136.74%
2018	24.85 Million USD	2.56%
2017	24.23 Million USD	15.32%
2016	21.01 Million USD	-27.38%
2015	28.93 Million USD	0.0%

Year	Total Debt	Total Debt Growth
2024 Q3	47.83 Million USD	1193194.08%
2024 Q1	44.17 Million USD	9.33%
2024 Q2	62.09 Million USD	40.56%
2023 Q3	70.59 Million USD	-42.92%
2023 FY	40.4 Million USD	-45.93%
2023 Q2	123.67 Million USD	110.89%
2023 Q1	58.64 Million USD	-21.53%
2023 Q4	40.4 Million USD	-42.76%
2022 Q4	74.73 Million USD	5.97%
2022 FY	74.73 Million USD	70.51%
2022 Q3	70.52 Million USD	69.23%
2022 Q1	52.38 Million USD	19.52%
2022 Q2	41.67 Million USD	-20.45%
2021 Q1	55.54 Million USD	0.0%
2021 FY	43.83 Million USD	-46.81%
2021 Q3	50.31 Million USD	-9.85%
2021 Q4	43.83 Million USD	-12.88%
2021 Q2	55.81 Million USD	0.48%
2020 FY	82.4 Million USD	40.05%
2019 FY	58.83 Million USD	136.74%
2018 FY	24.85 Million USD	2.56%
2017 FY	24.23 Million USD	15.32%
2016 FY	21.01 Million USD	-27.38%
2015 FY	28.93 Million USD	0.0%

Peer Total Debt Comparison of PT Kalbe Farma Tbk.

Name	Total Debt	Total Debt Difference
AstraZeneca PLC	28.58 Billion USD	99.859%
Bristol-Myers Squibb Company PFD CONV 2	41.46 Billion USD	99.903%
CSPC Pharmaceutical Group Limited	99.64 Million USD	59.451%
Clarus Therapeutics Holdings, Inc.	42.26 Million USD	4.408%
Novartis AG	26.34 Billion USD	99.847%